|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Herpes Zoster | |||||
| Postherpetic Neuralgia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neuralgia | |||||
| Neuralgia, Postherpetic | |||||
| 3 | More general conditions related to this trial | ||||
| DNA Virus Infections | |||||
| Herpesviridae Infections | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Neuromuscular Diseases | |||||
| Pain | |||||
| Peripheral Nervous System Diseases | |||||
| Signs and Symptoms | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Varicella-zoster vaccine | |||||
| Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| Department of Veterans Affairs | |||||
| Merck | |||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||